Alexandra Weber Morales[email protected]Clinical NewsFacing Mo-99 shortage, nuclear medicine economizesWhat would a world without molybdenum-99 (Mo-99) look like? That's a question U.S. nuclear medicine physicians are contemplating as limited Mo-99 supplies decay by half every 66 hours.June 10, 2009Page 1 of 1Top StoriesMolecular ImagingWill FAP-targeted theranostics live up to their promise?Fibroblast activation protein (FAP)-targeted theranostics is an emerging technique in the battle against cancer.CTNew evidence emerges on U.K. radiology’s workforce crisisArtificial IntelligenceBarcelona radiomics team reveals AI progress in liver cancerArtificial IntelligenceMomentum builds for AI use in intracranial hemorrhage casesSponsor ContentJoin us on 17 June for a webinar
